X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Celebrating Medicare’s 56th anniversary

By Gabby Migliara  |    July 30, 2021
For 56 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical needs. Today marks Medicare’s anniversary and to...   Read More

Increasing global access to vaccines by optimizing production

By Megan Van Etten  |    July 29, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.   Read More

Recognizing Hepatitis R&D on World Hepatitis Day

By Andrew Powaleny  |    July 28, 2021
Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, with types A, B, C most common. In 2018, the Centers for Disease...   Read More

340B hospitals among those that provide lowest levels of community benefit across the country

By Nicole Longo  |    July 27, 2021
The 340B program reached $38 billion in sales at the discounted price in 2020. This is a 27% increase over sales in 2019, and the program is now more than four times the size it was in 2014....   Read More

We Work for Health: Discovering champions, even amid challenging times

By Ryan Garofalo  |    July 26, 2021
For over a decade, We Work For Health has sought to highlight the incredible men and women who create hope for patients, serve as changemakers and ensure the continued vibrancy of our economy. We...   Read More

Government “negotiation” could have devastating consequences for Medicare enrollees

By Gabby Migliara  |    July 23, 2021
Some members of Congress are considering significant changes to Medicare that could have a devastating effect on millions of Americans. Proponents call these changes government “negotiation,” but...   Read More

Guest post: Retired medics return to the field to take on vaccine delivery and disaster relief

By Guest Contributor  |    July 23, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020

By Tim McClung  |    July 22, 2021
PhRMA member companies’ robust investment in research and development (R&D) has led to advances and discoveries that are transforming health care and our approach to treating patients for a broad...   Read More

Protecting Medicare from government interference

By Gabby Migliara  |    July 21, 2021
For more than a decade, Medicare Part D has provided seniors and people with disabilities with affordable and comprehensive prescription medicine coverage. Several surveys show that more than 9 in...   Read More

Guest Post: A patient’s story of the long-term health impacts of COVID-19

By Guest Contributor  |    July 21, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help

By Emilie Signora  |    July 20, 2021
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more...   Read More

Dose sharing as a part of the COVID-19 global vaccine equity strategy

By Megan Van Etten  |    July 20, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.   Read More

Data shows voters strongly support protecting access to their medicines

By Mark Keida  |    July 15, 2021
In our current health care system, the Medicare Part D program helps ensure seniors and people with disabilities have access to the prescription medicines they need. While more than 90% of seniors...   Read More

Promoting global vaccine equity while protecting innovation

By Megan Van Etten  |    July 15, 2021
America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The...   Read More

Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

By Tom Wilbur  |    July 2, 2021
As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...   Read More

PhRMA awards $75,000 to fund initiatives to reduce health inequities

By Lori Reilly  |    July 1, 2021
As part of PhRMA’s continuing commitment to build a more just and equitable health care system, we recently awarded $75,000 through our Collaborative Actions to Reach Equity (CAREs) grant program...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates